Hung N Luu1,2, Jirong Long1, Wanqing Wen1, Ying Zheng3, Qiuyin Cai1, Yu-Tang Gao4, Wei Zheng1, Xiao-Ou Shu5. 1. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN, 37203-1738, USA. 2. Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, USA. 3. Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China. 4. Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. 5. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2525 West End Avenue, Suite 600 (IMPH), Nashville, TN, 37203-1738, USA. xiao-ou.shu@vanderbilt.edu.
Abstract
PURPOSE: While leukocyte telomere length (TL) has been associated with breast cancer risk, limited information is available regarding the role of genetically-determined TL on breast cancer risk. We investigated whether aggregated TL-associated variants are associated with the risk of breast cancer in 2,865 breast cancer cases and 2,285 controls from the Shanghai Breast Cancer Genetics Study. METHODS: Six genetic variants, identified through a genome-wide association study (GWAS) of TL in European-ancestry participants, were included in the study. A separate sample [n = 1,536, from the Shanghai Women's Health Study (SWHS), for whom information on both phenotypical leukocyte TL and genetic information was collected] was used to evaluate the association of six variants with TL in Asians. Three genetic risk scores (GRSs), based on the number of alleles associated with shorter TL that each individual carries for the six variants, were derived for the study: un-weighted, internally weighted (from the SWHS), and externally weighted (from the European-ancestry GWAS study), and evaluated for their association with breast cancer risk by applying logistic regression analysis. RESULTS: Both internally and externally weighted GRSs were significantly associated with a decreased risk of breast cancer (OR 0.83, 95 % CI 0.72-0.95 and OR 0.84, 95 % CI 0.74-0.96, respectively, for tertile 3 vs. tertile 1). Non-genetic risk factors for breast cancer (i.e., age, years of menstruation/reproduction, oral contraceptive usage, and BMI) did not modify the association between GRSs and the risk of breast cancer. CONCLUSION: Our results suggest that short TL, determined by genetic factors, may be associated with a reduced susceptibility to breast cancer.
PURPOSE: While leukocyte telomere length (TL) has been associated with breast cancer risk, limited information is available regarding the role of genetically-determined TL on breast cancer risk. We investigated whether aggregated TL-associated variants are associated with the risk of breast cancer in 2,865 breast cancer cases and 2,285 controls from the Shanghai Breast Cancer Genetics Study. METHODS: Six genetic variants, identified through a genome-wide association study (GWAS) of TL in European-ancestry participants, were included in the study. A separate sample [n = 1,536, from the Shanghai Women's Health Study (SWHS), for whom information on both phenotypical leukocyte TL and genetic information was collected] was used to evaluate the association of six variants with TL in Asians. Three genetic risk scores (GRSs), based on the number of alleles associated with shorter TL that each individual carries for the six variants, were derived for the study: un-weighted, internally weighted (from the SWHS), and externally weighted (from the European-ancestry GWAS study), and evaluated for their association with breast cancer risk by applying logistic regression analysis. RESULTS: Both internally and externally weighted GRSs were significantly associated with a decreased risk of breast cancer (OR 0.83, 95 % CI 0.72-0.95 and OR 0.84, 95 % CI 0.74-0.96, respectively, for tertile 3 vs. tertile 1). Non-genetic risk factors for breast cancer (i.e., age, years of menstruation/reproduction, oral contraceptive usage, and BMI) did not modify the association between GRSs and the risk of breast cancer. CONCLUSION: Our results suggest that short TL, determined by genetic factors, may be associated with a reduced susceptibility to breast cancer.
Entities:
Keywords:
Breast cancer; Reduced risk; Telomere length-associated variants
Authors: Mariuca Vasa-Nicotera; Scott Brouilette; Massimo Mangino; John R Thompson; Peter Braund; Jenny-Rebecca Clemitson; Andrea Mason; Clare L Bodycote; Stuart M Raleigh; Edward Louis; Nilesh J Samani Journal: Am J Hum Genet Date: 2004-11-01 Impact factor: 11.025
Authors: Jing Shen; Marilie D Gammon; Mary Beth Terry; Patrick T Bradshaw; Qiao Wang; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella Journal: Breast Cancer Res Treat Date: 2012-04-12 Impact factor: 4.872
Authors: Karen A Pooley; Stig E Bojesen; Maren Weischer; Sune F Nielsen; Deborah Thompson; Ali Amin Al Olama; Kyriaki Michailidou; Jonathan P Tyrer; Sara Benlloch; Judith Brown; Tina Audley; Robert Luben; K-T Khaw; David E Neal; Freddie C Hamdy; Jenny L Donovan; Zsofia Kote-Jarai; Caroline Baynes; Mitul Shah; Manjeet K Bolla; Qin Wang; Joe Dennis; Ed Dicks; Rongxi Yang; Anja Rudolph; Joellen Schildkraut; Jenny Chang-Claude; Barbara Burwinkel; Georgia Chenevix-Trench; Paul D P Pharoah; Andrew Berchuck; Rosalind A Eeles; Douglas F Easton; Alison M Dunning; Børge G Nordestgaard Journal: Hum Mol Genet Date: 2013-07-29 Impact factor: 6.150
Authors: Mark M Iles; D Timothy Bishop; John C Taylor; Nicholas K Hayward; Myriam Brossard; Anne E Cust; Alison M Dunning; Jeffrey E Lee; Eric K Moses; Lars A Akslen; Per A Andresen; Marie-Françoise Avril; Esther Azizi; Giovanna Bianchi Scarrà; Kevin M Brown; Tadeusz Dębniak; David E Elder; Eitan Friedman; Paola Ghiorzo; Elizabeth M Gillanders; Alisa M Goldstein; Nelleke A Gruis; Johan Hansson; Mark Harland; Per Helsing; Marko Hočevar; Veronica Höiom; Christian Ingvar; Peter A Kanetsky; Maria Teresa Landi; Julie Lang; G Mark Lathrop; Jan Lubiński; Rona M Mackie; Nicholas G Martin; Anders Molven; Grant W Montgomery; Srdjan Novaković; Håkan Olsson; Susana Puig; Joan Anton Puig-Butille; Graham L Radford-Smith; Juliette Randerson-Moor; Nienke van der Stoep; Remco van Doorn; David C Whiteman; Stuart MacGregor; Karen A Pooley; Sarah V Ward; Graham J Mann; Christopher I Amos; Paul D P Pharoah; Florence Demenais; Matthew H Law; Julia A Newton Bishop; Jennifer H Barrett Journal: J Natl Cancer Inst Date: 2014-09-17 Impact factor: 11.816